Related Experiment Videos
MRI in organ transplantation.
Radiologic Clinics of North America
|March 1, 1987
Summary
Magnetic resonance imaging (MRI) offers potential for evaluating organ transplants. While loss of the corticomedullary border (CMC) can indicate rejection or acute tubular necrosis (ATN), its presence doesn't exclude rejection.
Area of Science:
- Radiology
- Transplant Medicine
- Medical Imaging
Background:
- Limited experience exists with Magnetic Resonance Imaging (MRI) in transplant patients.
- Normal transplant kidneys exhibit a distinct corticomedullary border (CMC) on T1-weighted MRI.
- Loss of CMC is associated with transplant rejection and acute tubular necrosis (ATN), but its presence does not rule out rejection.
Purpose of the Study:
- To explore the utility of MRI in evaluating organ transplant viability and detecting rejection.
- To investigate the spectrum of MRI findings in cyclosporine toxicity.
- To highlight the need for prospective studies to define MRI's role in transplantation.
Main Methods:
- Review of existing literature and case reports on MRI in organ transplantation.
- Analysis of MRI characteristics, including T1-weighted imaging and corticomedullary border definition.
- Consideration of magnetic resonance spectroscopy (MRS) and imaging for various organ transplants.
Main Results:
- A sharply defined corticomedullary border (CMC) on T1-weighted MRI is characteristic of normal transplant kidneys.
- Loss of CMC is observed in transplant rejection and some cases of ATN.
- The MRI findings in cyclosporine toxicity are not well-defined due to limited patient data.
Conclusions:
- MRI shows promise for assessing organ viability and early rejection detection in heart, liver, and pancreas transplants.
- Further prospective research is essential to establish definitive MRI protocols and diagnostic criteria in organ transplantation.
- While CMC changes are indicative, they are not solely diagnostic for rejection.